Literature DB >> 7040849

Hypertriglyceridemia: mechanisms, clinical significance, and treatment.

S M Grundy.   

Abstract

The association between hypertriglyceridemia and coronary heart disease is explored followed by a discussion of the mechanisms of the disorder and guidelines on patient evaluation and treatment.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7040849     DOI： 10.1016/s0025-7125(16)31433-x

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN： 0025-7125            Impact factor:   5.456


  9 in total

1.  Kinetic constants for receptor-dependent and receptor-independent low density lipoprotein transport in the tissues of the rat and hamster.

Authors:  D K Spady; J B Meddings; J M Dietschy
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

Review 2.  The evaluation and treatment of hypercholesterolemia in primary care practice.

Authors:  W L Peters; A H Goroll
Journal:  J Gen Intern Med       Date:  1986 May-Jun       Impact factor: 5.128

3.  Plasma and lipoprotein lipid responses to four hypolipid drugs.

Authors:  W R Hazzard; P W Wahl; C Gagne; D Applebaum-Bowden; G R Warnick; J J Albers
Journal:  Lipids       Date:  1984-02       Impact factor: 1.880

4.  Propranolol decreases splanchnic triacylglycerol storage in burn patients receiving a high-carbohydrate diet.

Authors:  Beatrice Morio; Oivind Irtun; David N Herndon; Robert R Wolfe
Journal:  Ann Surg       Date:  2002-08       Impact factor: 12.969

5.  Effect of moderate to very low fat defined formula diets on serum lipids in healthy subjects.

Authors:  J T Snook; J P DeLany; V M Vivian
Journal:  Lipids       Date:  1985-11       Impact factor: 1.880

6.  Fenofibrate therapy of hypertriglyceridaemia. Differential effects on LDL cholesterol level in type IV and in type IIb primary hyperlipoproteinaemia.

Authors:  D Sommariva; D Bonfiglioli; I Pogliaghi; C Ottomano; A Fasoli
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  Identical structural and receptor binding defects in apolipoprotein E2 in hypo-, normo-, and hypercholesterolemic dysbetalipoproteinemia.

Authors:  S C Rall; K H Weisgraber; T L Innerarity; R W Mahley
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

8.  Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients.

Authors:  Thomas W Jax; Ansgar J Peters; Gunnar Plehn; Frank-Chris Schoebel
Journal:  Cardiovasc Diabetol       Date:  2009-09-07       Impact factor: 9.951

9.  Relevance of hemostatic risk factors on coronary morphology in patients with diabetes mellitus type 2.

Authors:  Thomas W Jax; Ansgar J Peters; Gunnar Plehn; Frank-Chris Schoebel
Journal:  Cardiovasc Diabetol       Date:  2009-05-06       Impact factor: 9.951
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.